腺苷蛋氨酸治疗慢性乙型肝炎高胆红素血症  

Research on the Curative Efficacy of Ademetionine in Treating Hyperbilirubinemia for Chronic Hepatitis B Patients

作　　者：刘锋[1] 宋晓蓉 贾彬[3] 朱利红[4] 

机构地区：[1]眉山市人民医院感染科,四川眉山620010 [2]眉山市中医院内3科 [3]眉山市人民医院内3科 [4]眉山市人民医院党委办公室

出　　处：《华西医学》2011年第9期1284-1286,共3页West China Medical Journal

摘　　要：目的分析腺苷蛋氨酸治疗慢性乙型肝炎高胆红素血症的临床疗效。方法回顾性分析2010年1-12月28例接受腺苷蛋氨酸(2 000 mg静脉滴注,1次/d)治疗慢性乙型肝炎高胆红素血症患者的临床资料,并对腺苷蛋氨酸治疗慢性重症乙型肝炎高胆红素血症后症状、体征及实验室检测指标的改变情况进行总结,利用多因素logistic回归分析方法探索与疗效相关的预测因素。根据相关症状、体征和实验室结果的不同,将疗效分为显效、有效和无效3类。结果 28例患者使用腺苷蛋氨酸治疗4周后,显效20例(71.4%),有效4例(14.3%),无效4例(14.3%)。多因素logistic回归分析提示病程短、并发症少是影响腺苷蛋氨酸疗效的独立预测因素。结论腺苷蛋氨酸是治疗慢性乙型肝炎高胆红素血症有效,发病时间短及并发症少的患者退黄效果更好。Objective To investigate the curative efficacy of ademetionine in the treatment of hyperbilirubinemia for chronic hepatitis B patients. Methods The clinical data of 28 chronic hepatitis B patients with intrahepatic cholestasis receiving intravenous ademetionine treatment （2 000 rag per day） were retrospectively analyzed. Patients＇ symptoms, body signs and laboratory examination results were summarized, and predictors for efficacy were investigated using multiple regression analysis. In this study, the curative efficacy was classified into remarkable efficacy, efficacy and inefficacy, according to the clinical data. Results After one-month treatment with ademetionine, the percentage for remarkable efficacy, efficacy and inefficacy was 71. 4%, 14. 3%, and 14. 3% respectively. Multivariate logistic regression analysis showed that short disease duration and fewer complications were independent predictors for remarkable efficacy of ademetionine treatment. Conclusion Ademetionine is an effective agent for the treatment of hyperbilirubinemia in chronic hepatitis B patients, and the result is especially good for patients with short duration and fewer complications.

关 键 词：腺苷蛋氨酸 慢性乙型肝炎 高胆红素血症 

分 类 号：R512.62[医药卫生—内科学]